62.70 USD
↗ 1.58 (2.58%)LIVE (AS OF 11:44 AM EDT)
Bristol-Myers Squibb Co. (BMY) trades at $62.70 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Buy" and "Buy" respectively. Key drivers include exceptional Return on Equity (41.6%) and a bullish Golden Cross on the moving averages. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 21, 2026.